Unknown NA INTERVENTIONAL 2-arm NCT04015531

Hypofractionated Versus Conventional Fractionation Radiotherapy

Hypofractionated Versus Conventional Fractionation Radiation After Conservative Surgery or Mastectomy With Irradiation of Lymph Node Drainage: a Phase II Randomized Clinical Trial for the Evaluation of Acute Toxicity

Sponsor: Hospital da Baleia

Conditions Breast Cancer Radiation Toxicity

Interventions Conventional radiotherapy Hypofractionated radiotherapy

Updated 5 times since 2019 Last updated: Jul 10, 2019 Started: Jul 31, 2019 Primary completion: May 31, 2020 Completion: Dec 31, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Breast Cancer and Radiation Toxicity, this trial is ongoing. The trial is conducted by Hospital da Baleia and has accumulated 5 data snapshots since 2019. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Oct 2021 — Jul 2024 [monthly]

Unknown Status NA

Status: Not Yet Recruiting → Unknown Status
Jan 2021 — Oct 2021 [monthly]

Not Yet Recruiting NA
Aug 2019 — Jan 2021 [monthly]

Not Yet Recruiting NA

First recorded

Jul 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hospital da Baleia

Data source: Hospital da Baleia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.